Page last updated: 2024-10-22

acetazolamide and Bone Cancer

acetazolamide has been researched along with Bone Cancer in 2 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tauro, M1
Loiodice, F1
Ceruso, M1
Supuran, CT1
Tortorella, P1
ZANDER-PRINCIPATI, GE1
KUZMA, JF1

Other Studies

2 other studies available for acetazolamide and Bone Cancer

ArticleYear
Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.
    Bioorganic & medicinal chemistry letters, 2014, Jun-15, Volume: 24, Issue:12

    Topics: Bone Neoplasms; Carbonic Anhydrase Inhibitors; Cell Line; Diphosphonates; Enzyme Activation; Humans;

2014
REDUCTION OF STRONTIUM-90 BONE CANCER BY ZIRCONIUM CITRATE.
    International journal of radiation biology and related studies in physics, chemistry, and medicine, 1964, Volume: 8

    Topics: Acetazolamide; Animals; Bone Neoplasms; Chelating Agents; Citrates; Citric Acid; Metabolism; Mice; N

1964